Q1FY18 Results: Syngene International Ltd
Rohan Takalkar / 27 Jul 2017
Syngene International Limited reported its results for the quarter ended June 30, 2017 today. The company's total sales for Q1FY18 came in at Rs 291.1 crore, which represents a 0.07 per cent sequential decline and 6.05 per cent YoY increase.
Syngene International Limited reported its results for the quarter ended June 30, 2017 today.
The company's total sales for Q1FY18 came in at Rs 291.1 crore, which represents a 0.07 per cent sequential decline and 6.05 per cent YoY increase.
Its operating profit (EBIT) for the quarter amounted to Rs 96 crore and its EBIT margin stood at 32.98 per cent.
The company reported PAT of Rs 62 crore, which represents a sequential QoQ decline of 20.92 per cent and a YoY increase of 3.68 per cent.
During the quarter, the company signed a deal for further expansion of its research collaboration with Amgen Inc. This will expand the size and scope of services of the Syngene Amgen R&D Center.
The company has also signed a multi-year commercial manufacturing contract with a major Japanese pharma company to support an NCE for launch in the Japanese market. This is expected to boost its commercial manufacturing business.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.